Lucid Diagnostics LUCD Preferred Stock
Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by Lucid Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockValue.
The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lucid Diagnostics's preferred stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lucid Diagnostics's preferred stock?
- Lucid Diagnostics (LUCD) reported preferred stock of $10.13M in Q1 2026.
- How has Lucid Diagnostics's preferred stock changed year-over-year?
- Lucid Diagnostics's preferred stock decreased by 81.4% year-over-year, from $54.42M to $10.13M.
- What is the long-term trend for Lucid Diagnostics's preferred stock?
- Over 2 years (2023 to 2025), Lucid Diagnostics's preferred stock has grown at a 70.7% compound annual growth rate (CAGR), from $18.63M to $54.27M.
- What does preferred stock mean?
- Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.